Dr. William T. Leslie, MD

Dr. Leslie practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Leslie's NPI, 1538129275, was assigned on March 25, 2006. Dr. Leslie graduated from OHSU School of Medicine in 1978. Dr. Leslie holds Illinois license 036-058921.

Dr. Leslie's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Leslie's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Leslie is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Leslie to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leslie practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Leslie's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Leslie is board certified in hematology by the American Board of Internal Medicine. Dr. Leslie is licensed in Illinois.

Dmand AI lists chronic anemia, colorectal cancer, neutropenia and prostate cancer among the conditions Dr. Leslie treats.

CMS data shows 736 Medicare services from Dr. Leslie across 4 procedure codes in 2024, for 244 Medicare patients. Medicare paid $80,266 for them.

CMS counts 244 Medicare patients who saw Dr. Leslie in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leslie's median patient age at 73, with 51% women.

In 2024, Dr. Leslie wrote 1,102 Medicare Part D claims for 154 patients. 92% of them were for generic drugs. CMS names the drug for 848 of them, across 26 drugs with 11 or more claims each, at $124,308 in total drug cost. In 2023, CMS named 663 claims across 24 drugs.

Dr. Leslie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leslie as offering telehealth.

Dmand AI links 27 papers to Dr. Leslie, published from 2012 to 2021. 2021 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Murine-Derived and Antineoplastic Agents. Dr. Leslie has published most often in Clin Adv Hematol Oncol. Dr. Leslie's most frequent co-authors are Marta Batus, MD, Christopher L. Coogan, MD and Isaac R. Francis, MD.

Dmand AI links Dr. Leslie to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms, Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 9 general payments to Dr. Leslie from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Incyte Corporation paid the most, $144.

Dmand AI lists 1 award for Dr. Leslie, most recently CMS Stage 1 EHR in 2013.

Dr. Leslie graduated from OHSU School of Medicine in 1978. Dr. Leslie is a member of ASCO.

Dr. Leslie is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.